Status:
TERMINATED
Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS)
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
University of Copenhagen
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-38 years
Phase:
NA
Brief Summary
The incretin hormones are secreted from the gastrointestinal tract in response to nutrient ingestion, and are responsible for 70 % of insulin secretion in response to glucose. The incretin response is...
Eligibility Criteria
Inclusion
- Subjects who fulfill the Rotterdam criteria for PCOS. Age 18-38
Exclusion
- Other endocrine diseases or diseases known to influence glucose/insulin/fat metabolism
- Oral contraceptive administration within three months of study start
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT00647023
Start Date
February 1 2004
End Date
May 1 2006
Last Update
March 31 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.